Evidence map›Paper›PMID 30804705›Full record

ArticleMediators of inflammation2019

Inflammatory Microenvironment and Adipogenic Differentiation in Obesity: The Inhibitory Effect of Theobromine in a Model of Human Obesity In Vitro.

Maria Pia Fuggetta, Manuela Zonfrillo, Cristina Villivà, Enzo Bonmassar, Giampiero Ravagnan

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Lupenone-Rich Fraction Derived fromLife (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Maternal caffeine intake and DNA methylation in newborn cord blood.The American journal of clinical nutrition · 2022
    Article
  17. Article
  18. Anti-Inflammatory and Cytotoxicity Effects ofFoods (Basel, Switzerland) · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria Pia FuggettaInstitute of Translational Pharmacology CNR, Via Fosso del Cavaliere, 00133 Rome, Italy.ORCID 0000-0001-6588-1580
Manuela ZonfrilloInstitute of Translational Pharmacology CNR, Via Fosso del Cavaliere, 00133 Rome, Italy.
Cristina VillivàInstitute of Translational Pharmacology CNR, Via Fosso del Cavaliere, 00133 Rome, Italy.
Enzo BonmassarInstitute of Translational Pharmacology CNR, Via Fosso del Cavaliere, 00133 Rome, Italy.
Giampiero RavagnanInstitute of Translational Pharmacology CNR, Via Fosso del Cavaliere, 00133 Rome, Italy.
Istituto di Farmacologia Traslazionale · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveObesity is considered a clinic condition characterized by a state of chronic low-grade inflammation. The role of macrophages and adipocytokines in adipose tissue inflammation is in growing investigation. The physiopathological mechanisms involved in inflammatory state in obesity are not fully understood though the adipocytokines seem to characterize the biochemical link between obesity and inflammation. The aim of this work is to analyze the effect of theobromine, a methylxanthine present in the cocoa, on adipogenesis and on proinflammatory cytokines evaluated in a model of fat tissue inflammation in vitro.

methodsIn order to mimic in vitro this inflammatory condition, we investigated the interactions between human-like macrophages U937 and human adipocyte cell lines SGBS. The effect of theobromine on in vitro cell growth, cell cycle, adipogenesis, and cytokines release in the supernatants has been evaluated.

resultsTheobromine significantly inhibits the differentiation of preadipocytes in mature adipocytes and reduces the levels of proinflammatory cytokines as MCP-1 and IL-1

conclusionTheobromine reduces adipogenesis and proinflammatory cytokines; these data suggest its potential therapeutic effect for treating obesity by control of macrophages infiltration in adipose tissue and inflammation.

Indexed as

AdipocytesAdipogenesisCell CycleCell DifferentiationCell LineCell Line, TumorCytokinesHumansInflammationMacrophagesObesityTheobromineCytokinesTheobromine

Identifiers

PMID30804705
PMCPMC6360562
OpenAlexW2910451382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.